Home » Topics » BioWorld Science

BioWorld Science
RSS

GSK and Lyell Immunopharma collaborate to improve cell therapies for cancer

Oct. 9, 2019

Scenesse wins approval in U.S. for erythropoietic protoporphyria

Oct. 9, 2019

Tezepelumab reduces activation of matrix remodeling and inflammatory pathways

Oct. 9, 2019

FDA approves Wilate for hemophilia A

Oct. 9, 2019

MTPS-9579A dose-dependently inactivates airway tryptase for the treatment of asthma

Oct. 9, 2019

MinL4.0 RSV: a synthetic, live-attenuated vaccine against respiratory syncytial virus

Oct. 9, 2019

Preliminary data presented from phase I/II ASPIRO study of AT-132

Oct. 9, 2019

Selepressin does not improve vasopressor- and ventilator-free days in patients with septic shock

Oct. 9, 2019

Discovery of novel potent fully human FVIII mimetic BiAb, KY-1049

Oct. 9, 2019

New mouse model of diabetic cystopathy described

Oct. 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...